Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor

Cancer

Volumn 78, Issue 1, 1996, Pages 128-132

  Avery, Robert A ^a   Harris, Jules E ^b   Davis Jr , Chartes J ^c   Borgaonkar, Digamber S ^d   Byrd, John C ^e,f   Weiss, Raymond B ^e,f  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d MEDICAL CENTER OF DELAWARE   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

chemotherapy; cytogenetics; kidney neoplasms; renal medullary carcinoma; sickle cell trait

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; INTERFERON; INTERLEUKIN 2; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN; VINBLASTINE;

ADULT; ARTICLE; CANCER RESISTANCE; CHROMOSOME 3; CLINICAL ARTICLE; FEMALE; GENETIC SUSCEPTIBILITY; HEMOGLOBIN SC DISEASE; HUMAN; KIDNEY CARCINOMA; KIDNEY MEDULLA; MALE; MONOSOMY; NEGRO; PRIORITY JOURNAL; PROGNOSIS; SICKLE CELL TRAIT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CARCINOMA, MEDULLARY; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; MALE; SICKLE CELL TRAIT;

EID: 0029951560     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960701)78:1<128::AID-CNCR18>3.0.CO;2-1     Document Type: Article

References (13)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Ca Cancer J Clin 1996;65:5-27.
2. Hartman DS, Davis CJ Jr., Madewell JE, Friedman AC. Primary malignant renal tumors in the second decade of life: Wilms tumor versus renal cell carcinoma. J Urol 1982; 127:888-91.
3. Davis CJ Jr., Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995;19:1-11.
4. Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson N, Newmann RD. Collecting duct carcinoma of the kidney. Hum Pathol 1990;21:449-56.
5. Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 1995;195:83-5.
6. Malek RS, Omess PJ, Benson RC, Zincke H. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987; 82:236-8.
7. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs S, et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979;301:592-5.
8. Li FP, Decker HJH, Zbar B, Stanton Jr. VP, Kovacs G, Seizinger BR, et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional 3;8 translocation. Genetics of familial renal carcinoma. Ann Intern Med 1993;118:106-11.
9. Deisseroth A, Nienhuis A, Lawrence J, Giles R, Turner P, Ruddle FH. Chromosomal localization of human β-globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci USA 1978;75:1456-60.
10. Perkins AS, Vande Woude GF. Principles of molecular cell biology of cancer: oncogenes. In: Devita VT, Hellman S, Rosenberg SA, editor, Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: J.B. Lippincott Co, 1993:35-59.
11. Strohmeyer TG, Slamon DJ. Proto-oncogenes and tumor suppressor genes in human urological malignancies. J Urol 1994;151:1479-97.
12. Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH. Chemotherapy for metastatic nonsmall bronchogenic carcinoma, generation V - a randomized comparison of four cisplatin containing regimens. J Clin Oncol 1985;3:72-9.
13. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.